- Country: Brazil
- Summary: Acquisition of Supposedly Human Immunoglobulin 5 G Fa (*), Human Immunoglobulin Multipurpose 2.5 G Fa, Human Immunoglobulin 6G Iv Bottle/Ampolo (*), Ropivacaine 7.5 Mg/Ml Injectable Solution ...
- BRT Ref No: 123326944
- Deadline: 05 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90626/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Acquisition of supplies immunoglobulin human multipurpose 5 g FA (*), Human Immunoglobulin Multipurpose 2.5 G FA, Human Immunoglobulin 6G IV Bottle/ampoule (*), Ropivacain 7.5 mg/ml Solution Ampoule 20 L, Levobupivacain 0.5% + Epinephrine 9.1 MCG/ML SOL INJ FA 20ml, Evetiracetam 100 mg/ml Oral solution 150 ml (*), levethyiracet 100 mg/ml oral solution 100 ml (*), neomycin+polymyxinab+dexamethasone (0.5 %+6000ui+0.1 %) 5ml (*), ciprofloxacin+dexamethasone 0.3 %+0.1 % Col
UASG Code: 92301
Notice from: 24/07/2025 from 08:00 to 17:59 hs
Delivery From the proposal: from 07/24/2025 to 08:00
Human immunoglobulin, concentration 5 g, pharmaceutical form Liophile powder for injectable + diluent
Quantity: 12500
Human immunoglobulin, 2.5 g concentration, pharmaceutical form Liophile powder for injectable + diluent
Quantity: 25000
Human immunoglobulin, Concentration 6 g, pharmaceutical form lipyl powder for injectable + diluent
Quantity: 10400
Ropivacaine hydrochloride, dosage 0.75%, presentation injectable solution
Quantity: 14500
Levobupivacaine hydrochloride, composition associated with epinephrine bitartarato, 0.5% + 9.1mcg/ml, pharmaceutical form Injectable solution
Quantity: 14500
Levetiracetam, concentration 100 mg/ml, pharmaceutical form oral solution
Quantity: 2038
Quantity: 3060
Polymyxin B, composition associated with neomycin and dexamethasone, 6,000 IU concentration + 3.5 mg + 1 mg/ml, pharmaceutical form Ophthalmic suspension
Quantity: 11900
Ciprofloxacin hydrochloride, active ingredient associated with dexamethasone, dosage3.5 mg + 1 mg/ml, presentation ophthalmic solution
Tobramycin, composition associated with dexamethasone, concentration 3 mg + 1 Mg/ml, pharmaceutical form ophthalmic suspension
Quantity: 11900 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAcquisition of Supposedly Human Immunoglobulin 5 G Fa (*), Human Immunoglobulin Multipurpose 2.5 G Fa, Human Immunoglobulin 6G Iv Bottle/Ampolo (*), Ropivacaine 7.5 Mg/Ml Injectable Solution ... - Brazil Tender
The SAO PAULO STATE GOVERNMENT, a Government sector organization in Brazil, has announced a new tender for Acquisition of Supposedly Human Immunoglobulin 5 G Fa (*), Human Immunoglobulin Multipurpose 2.5 G Fa, Human Immunoglobulin 6G Iv Bottle/Ampolo (*), Ropivacaine 7.5 Mg/Ml Injectable Solution .... This tender is published on BrazilTenders under BRT Ref No: 123326944 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
